Teligent, Inc. to Hold Conference Call for First Quarter 2019 Results on Monday May 6th, 2019
May 02, 2019 14:15 ET
|
Teligent, Inc.
BUENA, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
Teligent Provides Update on Orphan Drug Complete Response Letter
April 22, 2019 08:45 ET
|
Teligent, Inc.
BUENA, N.J., April 22, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced that on April 16, 2019, its development...
Teligent, Inc. Management Comments on Recent Market Movements
April 12, 2019 15:00 ET
|
Teligent, Inc.
BUENA, N.J., April 12, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today provided commentary on the recent market movements...
Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.1%
April 04, 2019 08:54 ET
|
Teligent, Inc.
BUENA, N.J., April 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Announces FDA Approval of Fluocinonide Topical Solution USP, 0.05%
March 19, 2019 14:06 ET
|
Teligent, Inc.
BUENA, N.J., March 19, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. Announces Fourth Quarter and Year End 2018 Results
March 18, 2019 07:45 ET
|
Teligent, Inc.
BUENA, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth...
Teligent, Inc. to Present at the 31st Annual ROTH Conference Tuesday March 19, 2019
March 15, 2019 16:15 ET
|
Teligent, Inc.
BUENA, N.J., March 15, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at 31st Annual ROTH Conference March...
Teligent, Inc. Announces FDA Approval of Desonide Ointment, 0.05%
March 14, 2019 08:15 ET
|
Teligent, Inc.
BUENA, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
Teligent, Inc. to Hold Conference Call for Fourth Quarter 2018 Results
March 12, 2019 16:15 ET
|
Teligent, Inc.
BUENA, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 8:00am...
Teligent, Inc. to Present at The 8th Annual SVB Leerink Global Healthcare Conference Friday March 1, 2019
February 27, 2019 13:08 ET
|
Teligent, Inc.
BUENA, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at The 8th Annual SVB Leerink Global...